SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003273
Filing Date
2015-05-05
Accepted
2015-05-05 11:35:57
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20150331.htm 10-Q 2887211
2 EX-31.1 bmrn-ex311_201503317.htm EX-31.1 12611
3 EX-31.2 bmrn-ex312_201503318.htm EX-31.2 12615
4 EX-32.1 bmrn-ex321_201503319.htm EX-32.1 5861
  Complete submission text file 0001564590-15-003273.txt   18277703

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20150331.xml EX-101.INS 3648403
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20150331.xsd EX-101.SCH 64436
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20150331_cal.xml EX-101.CAL 103068
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20150331_def.xml EX-101.DEF 220045
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20150331_lab.xml EX-101.LAB 526658
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20150331_pre.xml EX-101.PRE 436452
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 15831273
SIC: 2834 Pharmaceutical Preparations